CEO, TwinStrand Biosciences
Andrews recently was named CEO of TwinStrand Biosciences, a duplex sequencing company focused on mutagens in pharmaceuticals and food additives. He previously was president and CEOI of Oncocyte and held senior roles at Thermo Fisher Scientific as president of the genetic sciences division. He founded The Bethesda Group and held management positions at Roche Molecular Diagnostics, Immucore Inc., and Abbott Diagnosticvs.
- October 2023
Added to: Agendia Inc. - Irvine, CA
Agendia is a gene expression profiling company advancing personalized early-stage breast cancer care.